Sheldon Sloan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 9 hours ago
Sheldon Sloan has an estimated net worth of at least $11.5 million*, as of May 20, 2026. They own 78,333 shares of SYRE stock. They have sold 86,291 shares of SYRE stock since 2021, for an estimated $6.0 million.
Sheldon Sloan $SYRE SEC Form 4 Insider Trading
Sheldon Sloan has filed a total of 8 insider trades in $SYRE since 2021. Their most recent trade was a sale of 21,306 shares, made on May 01, 2026. Their largest trade was a sale of 21,306 shares, made on May 01, 2026. We estimate that they now own 78,333 shares of $SYRE, worth an estimated $5.5 million.
Insider Trading at $SYRE
There have been a total of 36 insider trades reported at $SYRE since 2021, with 0 shares purchased and 287,750 shares sold. The most active insider traders in $SYRE stock have been Cameron Turtle, Sheldon Sloan, and Scott L Burrows. The most recent trade was a sale of 12,500 shares reported by Scott L Burrows (Chief Financial Officer), made on May 01, 2026.
History of Insider Stock Trades by Sheldon Sloan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
SYRE
|
Sale | 21,306 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 19,656 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 8,777 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 12,777 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 10,358 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 5,059 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 400 | May 01, 2026 | May 1, 2026, 9:34 p.m. |
|
SYRE
|
Sale | 7,958 | Apr 01, 2026 | April 3, 2026, 9:30 p.m. |
$SYRE Executives and Stock Owners with Insider Trades
-
Cameron Turtle, Chief Executive Officer
-
Sheldon Sloan, Chief Medical Officer
-
Scott L Burrows, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.